Fol. Biol. 2013, 59, 76-86

https://doi.org/10.14712/fb2013059020076

ADAM10/17-Dependent Release of Soluble c-Met Correlates with Hepatocellular Damage

K. Chalupský1, I. Kanchev1, O. Žbodáková1, H. Buryová1, M. Jiroušková1, V. Kořínek2, M. Gregor1, Radislav Sedláček1

1Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic
2Laboratory of Cell and Developmental Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic

Received February 2013
Accepted February 2013

Crossref Cited-by Linking

  • Ma\u0161ek Jan, Filipovic Iva, Van Hul Noémi, Belicová Lenka, Jirou\u0161ková Markéta, Oliveira Daniel V, Frontino Anna Maria, Hankeova Simona, He Jingyan, Turetti Fabio, Iqbal Afshan, \u010cervenka Igor, Sarnová Lenka, Verboven Elisabeth, Brabec Tomá\u0161, Björkström Niklas K, Gregor Martin, Dobe\u0161 Jan, Andersson Emma R: Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects. EMBO Mol Med 2024, 16, 2946. <https://doi.org/10.1038/s44321-024-00145-8>
  • Saha Nayanendu, Xu Kai, Zhu Zhongyu, Robev Dorothea, Kalidindi Teja, Xu Yan, Himanen Juha, de Stanchina Elisa, Pillarsetty Naga Vara Kishore, Dimitrov Dimiter S, Nikolov Dimitar B: Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells. Translational Oncology 2022, 15, 101265. <https://doi.org/10.1016/j.tranon.2021.101265>
  • De Herdt Maria J., van der Steen Berdine, Baatenburg de Jong Robert J., Looijenga Leendert H. J., Koljenovi\u0107 Senada, Hardillo Jose A.: The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies. Cancers 2022, 14, 1491. <https://doi.org/10.3390/cancers14061491>
  • Klotz Daniel Martin, Link Theresa, Goeckenjan Maren, Wimberger Pauline, Kuhlmann Jan Dominik: The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker. Molecular Oncology 2021, 15, 2491. <https://doi.org/10.1002/1878-0261.12939>
  • Xin Shuang, Fang Wenfeng, Li Jianwen, Li Delan, Wang Changzheng, Huang Quanfei, Huang Min, Zhuang Wei, Wang Xueding, Chen Likun: Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients. J Cancer Res Clin Oncol 2021, 147, 725. <https://doi.org/10.1007/s00432-020-03476-4>
  • Théret Nathalie, Bouezzeddine Fidaa, Azar Fida, Diab-Assaf Mona, Legagneux Vincent: ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment. Cancers 2021, 13, 1563. <https://doi.org/10.3390/cancers13071563>
Crossref Cited-by Linking logo